0001512563-13-000001.txt : 20130501 0001512563-13-000001.hdr.sgml : 20130501 20130501190849 ACCESSION NUMBER: 0001512563-13-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120701 FILED AS OF DATE: 20130501 DATE AS OF CHANGE: 20130501 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ai Bob Yunjun CENTRAL INDEX KEY: 0001512563 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32674 FILM NUMBER: 13804939 MAIL ADDRESS: STREET 1: 444 WASHINGTON BLVD STREET 2: SUITE 3338 CITY: JERSEY CITY STATE: NJ ZIP: 07310 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AOXING PHARMACEUTICAL COMPANY, INC. CENTRAL INDEX KEY: 0001060426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 650636168 STATE OF INCORPORATION: FL FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 444 WASHINGTON BLVD STREET 2: SUITE 3338 CITY: JERSEY CITY STATE: NJ ZIP: 07310 BUSINESS PHONE: 646-367-1747 MAIL ADDRESS: STREET 1: 444 WASHINGTON BLVD STREET 2: SUITE 3338 CITY: JERSEY CITY STATE: NJ ZIP: 07310 FORMER COMPANY: FORMER CONFORMED NAME: CHINA AOXING PHARMACEUTICAL COMPANY, INC. DATE OF NAME CHANGE: 20060707 FORMER COMPANY: FORMER CONFORMED NAME: CENTRAL AMERICAN EQUITIES CORP. DATE OF NAME CHANGE: 20060425 FORMER COMPANY: FORMER CONFORMED NAME: CENTRAL AMERICAN EQUITIES INC DATE OF NAME CHANGE: 19980429 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2012-07-01 1 0001060426 AOXING PHARMACEUTICAL COMPANY, INC. AXN 0001512563 Ai Bob Yunjun 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 0 0 0 1 ex-CFO This form is filed to report that I ceased to be an officer of the issuer as of July 1, 2012, and have no further filing obligation. Bob Yunjun Ai 2013-05-01